CARM

2.81% -0.0284

Dopo l'orario di chiusura: 1.02 0.0384 +3.91%

Carisma Therapeutics Inc (CARM)

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Carisma Therapeutics Inc Stock (CARM) Company Profile

Carisma Therapeutics Inc

(267) 491-6422

3675 MARKET STREET, PHILADELPHIA

Prossima data di guadagno

Ultimi documenti SEC

CARM's Discussions on Twitter

Carisma Therapeutics Inc Stock (CARM) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2023-07-06	Iniziato	Evercore ISI	Outperform
2023-05-31	Aggiornamento	Jefferies	Hold → Buy
2023-05-24	Iniziato	H.C. Wainwright	Buy
2023-04-14	Iniziato	Robert W. Baird	Outperform

Carisma Therapeutics Inc Borsa (CARM) Ultime notizie

Carisma Therapeutics Inc Azioni (CARM) Dati Finanziari

Carisma Therapeutics Inc (CARM)

Carisma Therapeutics Inc Stock (CARM) Company Profile

Carisma Therapeutics Inc Stock (CARM) Upgrades & Downgrades

Carisma Therapeutics Inc Borsa (CARM) Ultime notizie

Carly Rae Jepsen is engaged! Canadian singer shares happy news on social media: 'Very engaged over here' - Yahoo Canada Shine On

Carly Rae Jepsen Flaunts Blue Engagement Ring with Grammy Winning Fiancé - 2paragraphs Buzz

CRDF (Cardiff Oncology Inc) has impressive results - US Post News

Berkley W R Corp Sells 451,295 Shares of Cartica Acquisition Corp (NASDAQ:CITE) - MarketBeat

Carly Rae Jepsen is a fiancée! Singer announces engagement to Grammy-winning producer - USA TODAY

Carly Rae Jepsen Engaged to Producer Cole MGN: See Her RingE! Online - E! NEWS

'Very engaged over here': Singer Carly Rae Jepsen announces her engagement to music producer Cole M.G.N. - 9Honey Celebrity

Investing in Aclaris Therapeutics Inc (ACRS) Is Getting More Attractive - Knox Daily

Surprise! Carly Rae Jepsen Is Engaged!!! - PerezHilton.com

Nasdaq-Traded Cannabinoid Biotech Corbus Pharma Stock Plunges 60%, But Analysts Say 'Buy The Dip' Now - Benzinga

Carly Rae Jepsen announces engagement to boyfriend Cole MGN after two years of dating - Daily Mail

Carly Rae Jepsen Proclaims Herself ‘Very Engaged Over Here’ in Photoshoot Showing Off Ring From Fiancé Cole M.G.N. - Billboard

Carly Rae Jepsen Engaged to Producer Cole M.G.N. - AceShowbiz Media

Carly Rae Jepsen & Boyfriend Cole M.G.N. Are Engaged! - Just Jared

Cole M.G.N. Entertainment News, Photos, and Videos - Just Jared

A closer look at Cara Therapeutics Inc (CARA) is warranted - US Post News

Hancock Whitney Corp Has $737,000 Stock Holdings in Corcept Therapeutics Incorporated (NASDAQ:CORT) - Defense World

Where Are They Now? Carisma Therapeutics - Life Science Leader Magazine

Gabelli Funds LLC Has $120.74 Million Stake in Crane (NYSE:CR) - MarketBeat

Corbus Pharmaceuticals (NASDAQ:CRBP) PT Lowered to $40.00 at B. Riley - Defense World

Cosmic CRF shares hit 5% upper circuit on Rs 127-crore order win; details - Business Standard

Selling Buzz: Accuray Inc [ARAY] SVP Chief Financial Officer Pervaiz Ali sells 8,404 shares of the company - Knox Daily

A company insider recently sold 833 shares of Apollo Commercial Real Estate Finance Inc [ARI]. Should You Sale? - Knox Daily

Catalyst Pharmaceuticals (NASDAQ:CPRX) Hits New 1-Year High at $21.10 - MarketBeat

An analyst sees good growth prospects for Capricor Therapeutics Inc (CAPR) - SETE News

CMR Bolsters Funding for Mineral Exploration - TipRanks

Quest Partners LLC Purchases Shares of 934 Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) - Defense World

Mutual of America Capital Management LLC Increases Position in Corcept Therapeutics Incorporated (NASDAQ:CORT) - MarketBeat

CRISM Therapeutics Reports Positive Interim Results - TipRanks

Cairn Homes Advances Share Buyback Plan - TipRanks

Cero Therapeutics postpones special stockholders meeting By Investing.com - Investing.com Canada

Federated Hermes Inc. Sells 134 Shares of Cimpress plc (NASDAQ:CMPR) - Defense World

Aclaris Therapeutics neutral rating reiterated on phase 2a trial - Investing.com

Federated Hermes Inc. Acquires 399,860 Shares of Costamare Inc. (NYSE:CMRE) - Defense World

Aclaris Therapeutics (NASDAQ:ACRS) Receives “Neutral” Rating from HC Wainwright - Defense World

Review: AfrAId (2024) - It's A Stampede!

BTIG Research gives a Neutral recommendation for Apollo Commercial Real Estate Finance Inc (ARI) - Knox Daily

Aclaris Therapeutics (NASDAQ:ACRS) Receives "Neutral" Rating from HC Wainwright - MarketBeat

What technical indicators reveal about CARA stock - US Post News

The time has not yet come to remove your chips from the table: Cara Therapeutics Inc (CARA) - SETE News

Cara Therapeutics Inc (CARA)’s Day in Review: Closing at 0.26, Down by -2.85 - The Dwinnex

Carisma Therapeutics and Moderna Expand Partnership to Target Autoimmune Diseases - MyChesCo

Carisma Therapeutics to Present at Upcoming Conferences - Kilgore News Herald

Carisma Therapeutics CEO to Present at Key Industry Conferences - MSN

Carisma and Moderna partner on autoimmune disease therapies By Investing.com - Investing.com Australia

CARM’s valuation metrics: A comprehensive analysis - US Post News

Carisma and Moderna partner on autoimmune disease therapies - Investing.com

Carisma and Moderna Expand Collaboration to Develop Two In Vivo CAR-M Therapies for Autoimmune Diseases - PR Newswire

Carisma Therapeutics CEO to Present at Key Industry Conferences - MyChesCo

Carisma Therapeutics to Present at Upcoming Conferences - Nasdaq

Carisma Therapeutics to Present at Upcoming Conferences - PR Newswire

Carisma Therapeutics Inc Azioni (CARM) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Simile a CARM